EA Series Trust Acquires New Shares in LifeVantage Co. (NASDAQ:LFVN)

Posted by Defense World Staff on Oct 24th, 2023

EA Series Trust bought a new position in LifeVantage Co. (NASDAQ:LFVN – Free Report) in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 58,911 shares of the company’s stock, valued at approximately $256,000.

Several other hedge funds have also recently modified their holdings of LFVN. Tower Research Capital LLC TRC boosted its position in shares of LifeVantage by 117.5% during the third quarter. Tower Research Capital LLC TRC now owns 11,362 shares of the company’s stock valued at $42,000 after buying an additional 6,138 shares during the last quarter. Susquehanna International Group LLP bought a new stake in shares of LifeVantage in the fourth quarter worth approximately $93,000. American Century Companies Inc. raised its holdings in shares of LifeVantage by 30.3% during the first quarter. American Century Companies Inc. now owns 46,016 shares of the company’s stock valued at $219,000 after purchasing an additional 10,706 shares during the last quarter. State Street Corp lifted its position in LifeVantage by 7.6% during the first quarter. State Street Corp now owns 46,191 shares of the company’s stock valued at $220,000 after purchasing an additional 3,281 shares during the period. Finally, EP Wealth Advisors LLC purchased a new stake in LifeVantage in the first quarter worth approximately $234,000. Hedge funds and other institutional investors own 35.66% of the company’s stock.

Wall Street Analyst Weigh In

Separately, StockNews.com began coverage on shares of LifeVantage in a research note on Thursday, October 5th. They set a “strong-buy” rating for the company.

Get Our Latest Stock Report on LifeVantage

LifeVantage Stock Performance

Shares of NASDAQ:LFVN opened at $7.25 on Tuesday. The stock’s 50-day simple moving average is $6.50 and its two-hundred day simple moving average is $5.14. The stock has a market capitalization of $92.15 million, a price-to-earnings ratio of 36.25 and a beta of 0.86. LifeVantage Co. has a 52-week low of $3.04 and a 52-week high of $7.89.

LifeVantage (NASDAQ:LFVN – Get Free Report) last posted its quarterly earnings data on Monday, August 28th. The company reported $0.17 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.20 by ($0.03). LifeVantage had a return on equity of 9.27% and a net margin of 1.19%. The business had revenue of $54.22 million during the quarter. During the same quarter last year, the firm posted $0.01 earnings per share. As a group, equities analysts forecast that LifeVantage Co. will post 0.57 earnings per share for the current fiscal year.

LifeVantage Announces Dividend

The business also recently announced a None dividend, which was paid on Friday, September 22nd. Investors of record on Friday, September 8th were issued a $0.435 dividend. The ex-dividend date of this dividend was Thursday, September 7th. This represents a yield of 2.2%. LifeVantage’s dividend payout ratio is currently 70.00%.

Insider Activity at LifeVantage

In related news, Director Darwin Lewis purchased 4,124 shares of LifeVantage stock in a transaction on Friday, September 22nd. The stock was acquired at an average price of $6.94 per share, for a total transaction of $28,620.56. Following the completion of the transaction, the director now directly owns 89,408 shares in the company, valued at approximately $620,491.52. The purchase was disclosed in a filing with the SEC, which is available at the SEC website. In other news, Director Darwin Lewis purchased 4,124 shares of the company’s stock in a transaction on Friday, September 22nd. The stock was acquired at an average cost of $6.94 per share, for a total transaction of $28,620.56. Following the completion of the transaction, the director now directly owns 89,408 shares in the company, valued at approximately $620,491.52. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider Judd Dayton acquired 5,490 shares of the firm’s stock in a transaction dated Friday, August 25th. The shares were purchased at an average price of $4.95 per share, for a total transaction of $27,175.50. Following the completion of the transaction, the insider now directly owns 749,325 shares in the company, valued at $3,709,158.75. The disclosure for this purchase can be found here. Over the last three months, insiders have purchased 33,402 shares of company stock worth $175,227. Corporate insiders own 6.76% of the company’s stock.

LifeVantage Company Profile

(Free Report)

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.